SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-017024
Filing Date
2023-03-03
Accepted
2023-03-03 07:56:38
Documents
104
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2022_purplebiotech.htm   iXBRL 20-F 3024569
2 SHARE PURCHASE AGREEMENT BY AND AMONG PURPLE BIOTECH LTD., THE SHAREHOLDERS OF I f20f2022ex4-25_purple.htm EX-4.25 370008
3 LIST OF SUBSIDIARIES OF THE REGISTRANT f20f2022ex8-1_purple.htm EX-8.1 5811
4 CERTIFICATION f20f2022ex12-1_purple.htm EX-12.1 11007
5 CERTIFICATION f20f2022ex12-2_purple.htm EX-12.2 11159
6 CERTIFICATION f20f2022ex13-1_purple.htm EX-13.1 4568
7 CERTIFICATION f20f2022ex13-2_purple.htm EX-13.2 4507
8 CONSENT OF SOMEKH CHAIKIN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, A MEMB f20f2022ex15-1_purple.htm EX-15.1 1942
9 GRAPHIC image_001.jpg GRAPHIC 31744
10 GRAPHIC image_002.jpg GRAPHIC 12886
11 GRAPHIC image_003.jpg GRAPHIC 20330
12 GRAPHIC image_004.jpg GRAPHIC 8161
  Complete submission text file 0001213900-23-017024.txt   10170822

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE ppbt-20221231.xsd EX-101.SCH 131854
14 XBRL CALCULATION FILE ppbt-20221231_cal.xml EX-101.CAL 39143
15 XBRL DEFINITION FILE ppbt-20221231_def.xml EX-101.DEF 307521
16 XBRL LABEL FILE ppbt-20221231_lab.xml EX-101.LAB 696141
17 XBRL PRESENTATION FILE ppbt-20221231_pre.xml EX-101.PRE 331148
98 EXTRACTED XBRL INSTANCE DOCUMENT f20f2022_purplebiotech_htm.xml XML 1395658
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37643 | Film No.: 23701665
SIC: 2834 Pharmaceutical Preparations